Discontinued — last reported Q3 '19
DexCom Accrued Expenses decreased by 28.0% to $121.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.9%, from $110.80M to $121.80M. Over 5 years (FY 2020 to FY 2025), Accrued Expenses shows an upward trend with a 8.2% CAGR.
A steady balance is normal, but a rapid increase could indicate rising operational costs or delays in vendor invoicing.
This represents liabilities for expenses that have been incurred but not yet invoiced or paid, such as utilities, profes...
Standard current liability found in almost all corporate balance sheets.
accrued_expenses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $98.10M | $115.30M | $125.20M | $84.70M | $94.80M | $112.70M | $134.30M | $94.80M | $108.60M | $151.30M | $171.00M | $110.50M | $116.10M | $105.80M | $112.00M | $110.80M | $129.30M | $170.20M | $169.20M | $121.80M |
| QoQ Change | — | +17.5% | +8.6% | -32.3% | +11.9% | +18.9% | +19.2% | -29.4% | +14.6% | +39.3% | +13.0% | -35.4% | +5.1% | -8.9% | +5.9% | -1.1% | +16.7% | +31.6% | -0.6% | -28.0% |
| YoY Change | — | — | — | — | -3.4% | -2.3% | +7.3% | +11.9% | +14.6% | +34.3% | +27.3% | +16.6% | +6.9% | -30.1% | -34.5% | +0.3% | +11.4% | +60.9% | +51.1% | +9.9% |